![Kari Nadeau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kari Nadeau
No más puestos en curso
Perfil
Kari Nadeau is the founder of IgGenix, Inc. which was founded in 2019.
Antiguos cargos conocidos de Kari Nadeau.
Empresas | Cargo | Fin |
---|---|---|
IgGenix, Inc.
![]() IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
IgGenix, Inc.
![]() IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Kari Nadeau